Sean Grant
2022
In 2022, Sean Grant earned a total compensation of $2.5M as Chief Financial Officer at Vera Therapeutics, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,000 |
|---|---|
| Option Awards | $1,258,893 |
| Salary | $417,500 |
| Stock Awards | $627,750 |
| Total | $2,472,143 |
Grant received $1.3M in option awards, accounting for 51% of the total pay in 2022.
Grant also received $168K in non-equity incentive plan, $417.5K in salary and $627.8K in stock awards.
Rankings
In 2022, Sean Grant's compensation ranked 1,475th out of 5,760 executives tracked by ExecPay. In other words, Grant earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,475 out of 5,760 | 74th |
Division Manufacturing | 739 out of 3,136 | 76th |
Major group Chemicals And Allied Products | 288 out of 1,422 | 80th |
Industry group Drugs | 267 out of 1,323 | 80th |
Industry Pharmaceutical Preparations | 190 out of 969 | 80th |
Source: SEC filing on March 30, 2023.
Grant's colleagues
We found two more compensation records of executives who worked with Sean Grant at Vera Therapeutics in 2022.